Vision loss in Choroideremia progressively continues until people lose all their sight. For these individuals, retinal prosthetics can be surgically implanted to restore a small amount of vision.
There are currently two devices available today that patients can obtain. The Argus II by Second Sight has been approved by the FDA for use in patients in the United States with Retinitis Pigmentosa, a similar retinal disease. A second device, the Alpha IMS developed by Retina Implant AG, has been approved for use in the European Union.
The Choroideremia Research Foundation Inc. is an international, non-profit organization dedicated to raising funds to find a treatment or cure for Choroideremia, a rare inherited retinal degenerative disease that causes blindness.
Copyright © 2017 The Choroideremia Research Foundation Inc.